Patent 10444943
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
The initial instruction states "The USPTO ODP API returns no AIA trial proceedings for this patent as of the most recent ingest." My web search also did not directly yield any PTAB trial proceedings (IPR, PGR, CBM) for US10444943. The search results discuss the patent in the context of litigation in Texas Eastern District Court (which was already known from the previous prompt), and licensing agreements in Germany. Activemap LLC's own website lists US10444943 as one of its patents but does not mention any PTAB challenges. There are general links to PTAB search functions, but no specific results for this patent.
Therefore, I have confirmed that there are no PTAB proceedings on file for US10444943 based on the provided information and web search.
Proceedings overview
There are no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method) on file for US Patent 10444943. This means that the patent claims have not been challenged in an AIA trial before the Patent Trial and Appeal Board (PTAB).
Strategic summary
As of the current date, US Patent 10444943 has not been subjected to any AIA trial proceedings before the PTAB. This implies that all claims of the patent (claims 1-14) remain untested by this specific administrative challenge mechanism. For a defendant facing assertion of this patent, this means there is no existing PTAB record of claims being canceled, sustained, or narrowed, which could otherwise inform a defense strategy.
The absence of PTAB proceedings also indicates that no prior art grounds (under 35 U.S.C. §§ 102 or 103 for IPRs, or additional grounds for PGR/CBM) have been formally litigated and decided by the Board for this patent. Consequently, there is no estoppel against potential petitioners (or their privies) under 35 U.S.C. § 315(e)(2) for any prior art grounds that could have been raised. This leaves the full range of PTAB challenge options open to a new petitioner.
Recommended next steps
- If you are a defendant facing an assertion of US10444943, the absence of PTAB activity means that all claims are currently presumed valid as granted by the USPTO, without any PTAB-issued invalidity findings. An IPR, PGR, or CBM petition remains a viable defensive option to challenge the patent's validity based on prior art.
- Given the ongoing district court litigation in the Texas Eastern District Court, considering a PTAB challenge could be a strategic move to address validity outside of district court.
- Before filing a petition, a thorough prior art search would be crucial to identify strong grounds for challenging the patent's claims, especially since they have not been previously tested in AIA trials.
- If you are the patent owner (Activemap LLC), the lack of PTAB challenges to date could be seen as a positive, as the claims remain intact. However, in light of the district court litigation, it is prudent to be prepared for potential PTAB petitions from defendants seeking to invalidate claims. Robust claim construction and prior art analysis are essential to defend against such future challenges.
Generated 5/16/2026, 12:46:25 AM